General Information of the Compound
| Compound ID |
CP0402366
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-amino-N-[[5-benzyl-2-(cyclopropylmethoxy)phenyl]methyl]-3-(4-hydroxy-2,6-dimethylphenyl)propanamide;2,2,2-trifluoroacetic acid
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H35F3N2O5
|
||||||||||||||||||
| Molecular Weight |
572.624
|
||||||||||||||||||
| Canonical SMILES |
OC(=O)C(F)(F)F.Cc1cc(O)cc(C)c1C[C@H](N)C(=O)NCc1cc(Cc2ccccc2)ccc1OCC1CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C29H34N2O3.C2HF3O2/c1-19-12-25(32)13-20(2)26(19)16-27(30)29(33)31-17-24-15-23(14-21-6-4-3-5-7-21)10-11-28(24)34-18-22-8-9-22;3-2(4,5)1(6)7/h3-7,10-13,15,22,27,32H,8-9,14,16-18,30H2,1-2H3,(H,31,33);(H,6,7)/t27-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
SFQXDAZWHCHNTJ-YCBFMBTMSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01526, Delta-type opioid receptor
Protein ID: PT00983, Kappa-type opioid receptor
Protein ID: PT01549, Mu-type opioid receptor